4//SEC Filing
Benecchi Christopher 4
Accession 0001562180-24-006086
CIK 0001597553other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:04 PM ET
Size
8.6 KB
Accession
0001562180-24-006086
Insider Transaction Report
Form 4
Benecchi Christopher
Chief Operating Officer
Transactions
- Award
Common Stock
2024-08-05+16,200→ 23,242 total - Tax Payment
Common Stock
2024-08-05$8.96/sh−4,755$42,605→ 18,487 total
Footnotes (2)
- [F1]On February 13, 2024, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 40,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on August 5, 2024, resulting in the vesting of the PSUs as to 16,200 shares.
- [F2]Reflects beneficial ownership balance which includes 1,112 shares purchased on June 28, 2024 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001881403
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:04 PM ET
- Size
- 8.6 KB